Researchers at The University of Texas at Arlington have found a potential new pathway to regulate immune response and potentially control inflammatory diseases of the central nervous system such as meningitis and sepsis.
“We need to know what turns on inflammatory response to bacterial infection to be able to modulate the process,” said Subhrangsu Mandal, the UTA associate professor of chemistry who led the research.
“If we can do so, we can control inflammatory diseases of the central nervous system that have been hard to treat up to now, such as sepsis and meningitis, as well as cancer and muscular dystrophy, which can also be seen a kind of inflammation,” he added.
Mandal and his team’s research findings were published in Scientific Reports.
The researchers have found that the long non-coding RNA molecule HOTAIR present in white blood cells has the capacity to signal these cells to activate immune response in the presence of bacteria. RNA, or ribonucleic acid, is present in all living cells. Its primary role is to carry instructions from DNA.
“Knowing that HOTAIR has a role in the signaling pathway also means that we can use it as a biomarker for bacterial infection,” he added. “Simple blood tests could indicate infection much more quickly, enabling better treatment for patients of rapidly-moving diseases such as septic shock and meningitis, which have been hard to treat up to now.”
The researchers used the resources of UTA’s North Texas Genome Center to demonstrate that noncoding RNA expression – including HOTAIR – is induced in white blood cells treated with lipopolysaccharide, which are molecules found on the outer membrane of bacterial cells. The research showed that HOTAIR gene was expressed alongside cytokines, which are excreted by cells as part of immune response, and inflammatory response genes such as iNOS. As a result, it is possible to conclude that HOTAIR is a key regulator for pathogen-induced cytokine expression, immune response and inflammation.
“Long non-coding RNAs like HOTAIR are emerging as key regulators of cell signaling processes and many are expressed in immune cells and play a critical role in immune response,” Mandal said. “Previous research carried out with Marco Brotto in UTA’s College of Nursing and Health Innovation had already established a link between low flow of oxygen to tissues and HOTAIR, which has been linked to cancer.”
“Having a resource like the North Texas Genome Center really means that we can multiply our work looking at non-coding RNAs in general, a burgeoning field in biochemistry,” he added.
Fred MacDonnell, UTA chair of chemistry and biochemistry, congratulated Mandal on this new research.
“Basic science related to the pathways for immune response is critical as there have been very few successes up to now developing treatments for extreme inflammations like sepsis and meningitis, “ MacDonnell said.
The Latest on: Immune response
via Google News
The Latest on: Immune response
- Immune response variations across the COVID-19 spectrumon June 24, 2020 at 9:21 pm
A new study published on the preprint server medRxiv in June 2020 describes differences in the adaptive and innate immune response in mild, moderate, and severe COVID-19. This may mean that permanent ...
- UW joins drug trial aimed at preventing major COVID-19 killer: Haywire immune responseon June 24, 2020 at 6:48 am
UW is taking part in a clinical trial of a drug known as ruxolitinib, a government-approved medication given to bone marrow transplant recipients.
- Immune responses in beta-thalassaemia: heme oxygenase 1 reduces cytokine production and bactericidal activity of human leucocyteson June 24, 2020 at 2:18 am
Impaired immune cell functions may be the cause of this susceptibility, but detailed mechanisms have not been defined. In this study, we observed impaired production of IFN-gamma and IL-10 by whole ...
- Two doses of Oxford University’s coronavirus vaccine boosts immune response in pigson June 23, 2020 at 11:50 am
The Pirbright Institute, working in collaboration with the University of Oxford, announced on Tuesday that two doses of an experimental COVID-19 vaccine successfully produced a greater antibody ...
- Researchers use stem cells to model the immune response to COVID-19on June 23, 2020 at 11:29 am
Two members of the UCLA Broad Stem Cell Research Center have received a grant for work that could be helpful in developing a vaccine.
- R848 or influenza virus can induce potent innate immune responses in the lungs of neonatal miceon June 23, 2020 at 7:48 am
Innate immune responses are important to protect the neonatal lung, which becomes exposed to commensal and pathogenic microorganisms immediately after birth, at a time when both the lung and the ...
- Asymptomatic COVID-19 infections show weaker immune response: studyon June 22, 2020 at 3:27 am
A nurse treats a COVID-19 patient at an isolation ward in Ditan Hospital in Beijing, capital of China, June 19, 2020.(Xinhua/Peng Ziyang) BEIJING, June 22 (Xinhua) -- Chinese researchers have revealed ...
- BetterLife Pharma (OTCQB:BETRF) Looks to Immune Response Drug Interferon a2b as Potential Therapeutic for COVID-19on June 19, 2020 at 6:11 pm
BetterLife Pharma (BETRF) (BETR.CN) (NPAT.F), an emerging clinical stage pharmaceutical development company, announced recently that it is exploring the potential of using a patent-pending proprietary ...
- Asymptomatic COVID-19 Cases May Have Weaker Immune Responseson June 19, 2020 at 5:00 am
A new study finds that people who fail to develop COVID-19 symptoms may have a weaker immune response to the SARS-CoV-2 virus.
via Bing News